Kaplan Fox Advises Investors of Fulcrum Therapeutics, Inc. (FULC) to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - September 2, 2026) - Kaplan Fox Kilsheimer LLP is investigating...